James Spadaro
Interventional Cardiology · Rolla, MONPI 1063411999
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for interventional cardiology clinicians in MO, where the typical reported total is $10,448.
Across 67 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$184
- Amarin Pharma, Inc.$168
- E.r. Squibb & Sons, L.L.C.$115
- Boehringer Ingelheim$88
- Amgen$68
- Philips North America LLC$67
- plus $477 from 14 others
What the payments were for
- Food & beverage$1,166100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 11 | $184 |
| Amarin Pharma, Inc. | 10 | $168 |
| E.r. Squibb & Sons, L.L.C. | 8 | $115 |
| Boehringer Ingelheim | 6 | $88 |
| Amgen | 5 | $68 |
| Philips North America LLC | 1 | $67 |
| Abbott | 1 | $64 |
| Pfizer | 3 | $59 |
| AstraZeneca | 3 | $46 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
| Lundbeck LLC | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Vifor Pharma, Inc. | 2 | $28 |
| Abiomed | 1 | $21 |
| Irhythm Technologies, Inc. | 1 | $19 |
| Merck | 1 | $16 |
| Boston Scientific | 1 | $14 |
How this compares
$1,166 in reported general payments places this provider in the 10th percentile of 182 interventional cardiology providers in Missouri.
Other interventional cardiology in Rolla
- Stilianos EfstratiadisRolla$34K
- Joshua StolkerWashington$1.2M
- John LasalaSaint Louis$936K
- Harvey SerotaSaint Louis$752K
- Jasvindar SinghSaint Louis$696K
- Gerald MancusoKansas City$402K
- James GranthamKansas City$357K
- Matthew BunteKansas City$242K
- Alan ZajariasSaint Louis$203K
- Anish ThomasSaint Louis$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.